Elevance Health Inc (NYSE:ELV)
$ 539.18 0.6 (0.11%) Market Cap: 125.32 Bil Enterprise Value: 145.54 Bil PE Ratio: 20.38 PB Ratio: 3.09 GF Score: 92/100

Elevance Health Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 17, 2023 / 12:00PM GMT
Release Date Price: $459.74 (+3.11%)
Benjamin Hendrix
RBC Capital Markets, Research Division - Assistant VP

RBC Capital Markets Healthcare Conference. I'm Ben Hendrix, RBC's healthcare services and managed care analyst. We're pleased to kick off day 2 of the conference with Elevance Health, specifically management from the company's health care services and pharmacy benefit business, Carelon.

And with us this morning from management are Peter Haytaian, Executive Vice President and President of Carelon and Carelon Rx; Amy Mulderry, Chief Development Officer and CFO of Carelon; Paul Marchetti, President of Carelon Rx; and Stephen Tanal, Vice President, Investor Relations of Elevance Health.

Questions & Answers

Benjamin Hendrix
RBC Capital Markets, Research Division - Assistant VP

And with that, just we'll kick off with the question about the Carelon's management. You've noted early success in reaching your goal of Carelon managing at least 20% of Elevance's consolidated benefit expense with clear room for continued growth. Can you give us an updated outlook for integration of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot